These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20616409)

  • 1. Functional bowel disorders in Iranian population using Rome III criteria.
    Sorouri M; Pourhoseingholi MA; Vahedi M; Safaee A; Moghimi-Dehkordi B; Pourhoseingholi A; Habibi M; Zali MR
    Saudi J Gastroenterol; 2010; 16(3):154-60. PubMed ID: 20616409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.
    Roshandel D; Rezailashkajani M; Shafaee S; Zali MR
    Int J Colorectal Dis; 2006 Dec; 21(8):814-25. PubMed ID: 16565819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of irritable bowel syndrome and other functional gastrointestinal disorders in Uruguay.
    Guido V; Pontet Y; López V; Olano C
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(2):258-264. PubMed ID: 38644084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.
    Long Y; Huang Z; Deng Y; Chu H; Zheng X; Yang J; Zhu Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27412422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study.
    Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR
    J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    Ono M; Kato M; Miyamoto S; Tsuda M; Mizushima T; Ono S; Nakagawa M; Mabe K; Nakagawa S; Muto S; Shimizu Y; Kudo M; Katsuki S; Meguro T; Sakamoto N
    J Gastroenterol; 2018 Aug; 53(8):916-923. PubMed ID: 29305648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.
    Ballou S; Rangan V; Eidelberg A; Proctor S; McHenry N; Nee J; Iturrino J; Lembo A; Singh P
    Am J Gastroenterol; 2023 Aug; 118(8):1402-1409. PubMed ID: 37053553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India.
    Goyal O; Nohria S; Dhaliwal AS; Goyal P; Soni RK; Chhina RS; Sood A
    Indian J Gastroenterol; 2021 Apr; 40(2):144-153. PubMed ID: 33226570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria.
    Wang X; Luscombe GM; Boyd C; Kellow J; Abraham S
    World J Gastroenterol; 2014 Nov; 20(43):16293-9. PubMed ID: 25473186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
    Perveen I; Rahman MM; Saha M; Rahman MM; Hasan MQ
    Indian J Gastroenterol; 2014 May; 33(3):265-73. PubMed ID: 24664445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
    Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
    Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.